PFM Health Sciences’s Madison Square Garden MSGS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
Sell
-143,520
Closed -$28.7M 88
2019
Q2
$28.7M Sell
143,520
-14,710
-9% -$3.13M 0.54% 59
2019
Q1
$33.1M Sell
158,230
-42,630
-21% -$8.66M 0.73% 48
2018
Q4
$38.4M Sell
200,860
-108,930
-35% -$21.2M 1.02% 42
2018
Q3
$69.7M Buy
309,790
+88,639
+40% +$19.7M 1.02% 40
2018
Q2
$48.9M Buy
+221,151
New +$40.9M 0.77% 50

Other funds holding MSGS

PFM Health Sciences's MSGS Position: Q3 2019 in Review

PFM Health Sciences sold out of Madison Square Garden (MSGS) in Q3 2019, closing a stake of 143,520 shares — an estimated $28.7M sold.

PFM Health Sciences first reported a position in MSGS in Q2 2018 and held it in 5 quarters. The position peaked at $69.7M in Q3 2018. 288 funds tracked by Wall St. Rank hold MSGS as of Q3 2019.

  • PFM Health Sciences reported no remaining Madison Square Garden position as of Q3 2019 after selling out during the quarter.
  • PFM Health Sciences sold 143,520 Madison Square Garden shares in Q3 2019, an estimated $28.7M.
  • PFM Health Sciences first reported a position in Madison Square Garden in Q2 2018 and held it in 5 quarters.
  • PFM Health Sciences's Madison Square Garden position peaked at $69.7M in Q3 2018.
  • 288 funds tracked by Wall St. Rank held Madison Square Garden as of Q3 2019.

Based on PFM Health Sciences's 13F filing for Q3 2019, filed 14 Nov 2019.